Polish Microbiome Map
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04169867|
Recruitment Status : Unknown
Verified November 2019 by Ardigen.
Recruitment status was: Recruiting
First Posted : November 20, 2019
Last Update Posted : November 20, 2019
|Condition or disease||Intervention/treatment|
|Melanoma Healthy Volunteers Microbiome Metagenome Immunotherapy||Biological: Collection of stool samples|
|Study Type :||Observational|
|Estimated Enrollment :||1160 participants|
|Official Title:||Polish Microbiome Map|
|Actual Study Start Date :||January 1, 2018|
|Estimated Primary Completion Date :||July 31, 2020|
|Estimated Study Completion Date :||December 31, 2020|
This cohort will consist of 1000 healthy volunteers from Poland.
This cohort will consist of 160 patients with melanoma.
Biological: Collection of stool samples
Patients receiving routine treatment (immunotherapy using anti-PD1 / anti-PDL1 and / or anti CTLA4 antibodies), financed by the Polish National Health Fund (NFZ).
- Microbial diversity in stool samples [ Time Frame: Inclusion ]Microbial DNA - stool samples sequenced by next-generation sequencing platform.
- Eating habits and health survey [ Time Frame: Inclusion ]It includes questions about healthy volunteers' and patients' eating habits that may relate to their health.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04169867
|Contact: Anna Philips, PhD||+48 61 852 89 email@example.com|
|Contact: Emilia Strycharz-Angrecka||+48 12 340 94 firstname.lastname@example.org|
|The Institute of Bioorganic Chemistry, Polish Academy of Sciences||Recruiting|
|Principal Investigator:||Anna Philips, PhD||The Institute of Bioorganic Chemistry, Polish Academy of Sciences|
|Principal Investigator:||Jan Majta||Ardigen|